Atrial fibrillation patients saw 69% lower risk with common blood thinners

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: ScienceDaily

What happened

Direct oral anticoagulants cut the risk of serious clinical events by 69% in atrial fibrillation patients with an intermediate risk of stroke, according to the randomized SINGLE-AF trial.

Key facts

  • Direct oral anticoagulants cut the risk of serious clinical events by 69% in atrial fibrillation patients with an intermediate risk of stroke, according to the randomized SINGLE-AF trial.
  • Reported by ScienceDaily and published Sun, 27 Sep 2026 13:41:36 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Sources

The original report was published by ScienceDaily. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at ScienceDaily

Related WorldPing coverage

Blood test could gauge if a baby has a dangerous infection in 15 minutesWorldPing
New Scientist

Blood test could gauge if a baby has a dangerous infection in 15 minutes

Feverish babies in hospital are often assumed to have a serious bacterial infection and are treated with antibiotics.But a test that gauges whether the infection is bacterial or viral, which tend to be milder, could prevent unnecessary drug use…

Brief by WorldPing · Original reporting by New Scientist